Aprea Therapeutics
APRE
APRE
24 hedge funds and large institutions have $521K invested in Aprea Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
53% less capital invested
Capital invested by funds: $1.11M → $521K (-$589K)
Holders
24
Holding in Top 10
–
Calls
$186K
Puts
$4K
Top Buyers
| 1 | +$16.9K | |
| 2 | +$13.9K | |
| 3 | +$7.96K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.53K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$4.18K |
Top Sellers
| 1 | -$40.2K | |
| 2 | -$34K | |
| 3 | -$13K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$13K |
| 5 |
Morgan Stanley
New York
|
-$12K |